NEW YORK (GenomeWeb) - Luminex reported after the close of the market Monday a 6 percent rise in its second quarter revenues, driven by a 22 percent jump in assay revenues.

For the three-month period ended June 30, Luminex's revenues rose to $58.9 million from $55.6 million in the same period a year earlier, topping the consensus Wall Street estimate of $57 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.